Pathogen-Associated Autoimmunity
Cross-source consensus on Pathogen-Associated Autoimmunity from 1 sources and 7 claims.
1 sources · 7 claims
Uses
How it works
Benefits
Highlighted claims
- Pathogen-triggered immune activation can produce antibodies that crossreact with human tissue through molecular mimicry. — Exposome and Autoimmunity: Food, Chemical, and Pathogen Immune Reactivity
- The diagnostic goal is to identify pathogens whose antibodies structurally crossreact with human tissue, not only to confirm active infection. — Exposome and Autoimmunity: Food, Chemical, and Pathogen Immune Reactivity
- Pathogens are described as driving autoimmunity through antigen release and gut barrier disruption. — Exposome and Autoimmunity: Food, Chemical, and Pathogen Immune Reactivity
- EBV is presented as crossreacting with lupus-associated antigens at about 70–80% structural homology. — Exposome and Autoimmunity: Food, Chemical, and Pathogen Immune Reactivity
- Chlamydia antibodies are described as crossreacting with myelin basic protein and MOG, which are relevant to multiple sclerosis pathology. — Exposome and Autoimmunity: Food, Chemical, and Pathogen Immune Reactivity
- Mold antibodies can identify both exposure or colonization and crossreactivity with cochlin in the inner ear. — Exposome and Autoimmunity: Food, Chemical, and Pathogen Immune Reactivity
- Treating EBV is presented as potentially reducing autoimmune antibody burden in lupus patients. — Exposome and Autoimmunity: Food, Chemical, and Pathogen Immune Reactivity